Prevention: Direct FY2013 Prevention of Mother-to-Child Transmission Program Results

Countries Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results)1 Number of HIV+ pregnant women receiving ARV prophylaxis Estimated infant HIV infections averted2
Angola 83,000 1,000 300
Botswana3 NA NA NA
Burma3 NA NA NA
Burundi 128,300 1,000 300
Cambodia 80,800 200 58
Cameroon 83,400 4,000 1,200
Côte d'Ivoire 470,700 13,200 4,000
Democratic Republic of the Congo 313,200 4,600 1,400
Dominican Republic 62,900 200 49
Ethiopia 1,390,800 18,300 5,600
Ghana3 NA NA NA
Guyana 10,600 48 15
Haiti 236,200 5,000 1,500
India3 NA NA NA
Indonesia3 NA NA NA
Kenya 1,245,700 55,100 15,800
Lesotho 27,100 7,700 2,400
Malawi 469,700 35,700 10,900
Mozambique 930,500 88,500 26,300
Namibia 55,200 4,300 1,300
Nigeria 1,808,500 46,500 13,900
Papua New Guinea3 NA NA NA
Russia3 NA NA NA
Rwanda 150,300 4,300 1,300
South Africa 913,400 222,100 68,000
South Sudan 16,500 700 200
Swaziland 26,600 9,500 2,900
Tanzania 1,425,100 55,600 17,000
Uganda 1,508,400 88,300 27,000
Ukraine3 NA NA NA
Vietnam 358,600 1,300 400
Zambia 530,100 54,700 16,400
Zimbabwe 457,400 59,200 17,600
Asia Region3 NA NA NA
Caribbean Region3 NA NA NA
Central America3 NA NA NA
Central Asia3 NA NA NA
Total 12,783,000 781,048 235,822
All numbers greater than 100 have been rounded off to the nearest 100. 
All results reflect accomplishments through September 30, 2013.
1This indicator has two components: 1) the number of women with known positive HIV infection attending an ANC for a new pregnancy over the last reporting period; and 2) the number of women attending ANC, Labor and Delivery sites who were tested for HIV and received results (which is also captured under the testing and counseling results).  The previous PMTCT indicator: “the number of pregnant women receiving PMTCT services” included only women who were counseled and tested and received their test results.  For further information, refer to Indicator P1.1.D in the PEPFAR Next Generation Indicator Reference Guide Version 1.2 on
2PEPFAR PMTCT country programs report PMTCT ARV uptake by regimen (ART for HIV-positive pregnant women eligible for treatment, maternal AZT, maternal triple ARV prophylaxis, and single dose nevirapine).  The method used to estimate infant HIV infections averted now accounts for the different probabilities of transmission for each of the different regimens.
3"NA" refers to countries or regions where USG did not support or did not directly support PMTCT or PMTCT ARV prophylaxis programs. 

Back to Top U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA